Document is current
Any future updates will be listed below
-
Authors
Héma, Alimatou
Soulama, Ben I.
Sawadogo, Jean
Ouédraogo, Amidou Z.
Hien, Denise
Nébié, Issa
Houard, Sophie
Ouédraogo, Alphonse
Tiono, Alfred B.
Sanou, Mahamoudou
Sirima, Sodiomon B.
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM, RIA2018V-2308-ShigaPlexIM)
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 28 October 2025
First Online: 24 November 2025
Declaration
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki (2013 revision). Ethics approval was obtained from the Health Research Ethics Committee (HREC) of Burkina Faso (Approval No. 2020-3-055 dated 25 March 2020, Protocol Version 1.0). The trial was registered at ClinicalTrials.gov (Registration No. NCT04312906). Written informed consent was obtained from the parents or legal guardians of all participating children.
: Not applicable.
: The authors declare no competing interests.
: The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
